| Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort TA Williams, JWM Lenders, P Mulatero, J Burrello, M Rottenkolber, ... The lancet Diabetes & endocrinology 5 (9), 689-699, 2017 | 678 | 2017 |
| Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature F Acevedo, R Baudrand, LM Letelier, P Gaete International Journal of Infectious Diseases 12 (4), 358-362, 2008 | 236 | 2008 |
| The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment A Vaidya, P Mulatero, R Baudrand, GK Adler Endocrine reviews 39 (6), 1057-1088, 2018 | 231 | 2018 |
| High sodium intake is associated with increased glucocorticoid production, insulin resistance and metabolic syndrome R Baudrand, C Campino, CA Carvajal, O Olivieri, G Guidi, G Faccini, ... Clinical endocrinology 80 (5), 677-684, 2014 | 212 | 2014 |
| Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics A Riquelme, M Arrese, A Soza, A Morales, R Baudrand, RM Pérez‐Ayuso, ... Liver international 29 (1), 82-88, 2009 | 201 | 2009 |
| Continuum of renin-independent aldosteronism in normotension R Baudrand, FJ Guarda, C Fardella, G Hundemer, J Brown, G Williams, ... Hypertension 69 (5), 950-956, 2017 | 171 | 2017 |
| The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study JM Brown, C Robinson-Cohen, MA Luque-Fernandez, MA Allison, ... Annals of internal medicine 167 (9), 630-641, 2017 | 155 | 2017 |
| Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism TA Williams, J Burrello, LA Sechi, CE Fardella, J Matrozova, C Adolf, ... Hypertension 72 (3), 641-649, 2018 | 117 | 2018 |
| Overexpression of 11β-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients R Baudrand, CA Carvajal, A Riquelme, M Morales, N Solis, M Pizarro, ... Obesity surgery 20, 77-83, 2010 | 78 | 2010 |
| El tejido graso como modulador endocrino: Cambios hormonales asociados a la obesidad R BAUDRAND B, E ARTEAGA U, M MORENO G Revista médica de Chile 138 (10), 1294-1301, 2010 | 70 | 2010 |
| The low-renin hypertension phenotype: genetics and the role of the mineralocorticoid receptor R Baudrand, A Vaidya International Journal of Molecular Sciences 19 (2), 546, 2018 | 68 | 2018 |
| Cortisol dysregulation in obesity-related metabolic disorders R Baudrand, A Vaidya Current Opinion in Endocrinology, Diabetes and Obesity 22 (3), 143-149, 2015 | 66 | 2015 |
| Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis M Pizarro, N Solís, P Quintero, F Barrera, D Cabrera, ... Liver International 35 (9), 2129-2138, 2015 | 65 | 2015 |
| Dietary sodium restriction increases the risk of misinterpreting mild cases of primary aldosteronism R Baudrand, FJ Guarda, J Torrey, G Williams, A Vaidya The Journal of Clinical Endocrinology & Metabolism 101 (11), 3989-3996, 2016 | 64 | 2016 |
| Aldosterone production and signaling dysregulation in obesity A Vecchiola, CF Lagos, CA Carvajal, R Baudrand, CE Fardella Current hypertension reports 18, 1-9, 2016 | 60 | 2016 |
| Statin use and adrenal aldosterone production in hypertensive and diabetic subjects R Baudrand, LH Pojoga, A Vaidya, AE Garza, PA Vöhringer, ... Circulation 132 (19), 1825-1833, 2015 | 59 | 2015 |
| Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects C Campino, A Martinez-Aguayo, R Baudrand, CA Carvajal, M Aglony, ... American journal of hypertension 26 (4), 481-487, 2013 | 57 | 2013 |
| Caveolin 1 modulates aldosterone‐mediated pathways of glucose and lipid homeostasis R Baudrand, N Gupta, AE Garza, A Vaidya, JA Leopold, PN Hopkins, ... Journal of the American Heart Association 5 (10), e003845, 2016 | 54 | 2016 |
| Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity GL Hundemer, R Baudrand, JM Brown, G Curhan, GH Williams, A Vaidya The Journal of Clinical Endocrinology & Metabolism 102 (6), 1835-1843, 2017 | 50 | 2017 |
| Overexpression of 11β‐hydroxysteroid dehydrogenase type 1 in visceral adipose tissue and portal hypercortisolism in non‐alcoholic fatty liver disease R Candia, A Riquelme, R Baudrand, CA Carvajal, M Morales, N Solís, ... Liver International 32 (3), 392-399, 2012 | 50 | 2012 |
Cristian A. CarvajalAssociate Professor, Endocrinology Department, Medicine, Pontificia Universidad Católica de Chile在 med.puc.cl 的电子邮件经过验证
